Frontiers in Neurology (Jan 2022)
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium
- Gregory D. Scott,
- Gregory D. Scott,
- Moriah R. Arnold,
- Thomas G. Beach,
- Christopher H. Gibbons,
- Anumantha G. Kanthasamy,
- Russell M. Lebovitz,
- Afina W. Lemstra,
- Leslie M. Shaw,
- Charlotte E. Teunissen,
- Henrik Zetterberg,
- Henrik Zetterberg,
- Henrik Zetterberg,
- Henrik Zetterberg,
- Henrik Zetterberg,
- Angela S. Taylor,
- Todd C. Graham,
- Bradley F. Boeve,
- Stephen N. Gomperts,
- Neill R. Graff-Radford,
- Charbel Moussa,
- Kathleen L. Poston,
- Liana S. Rosenthal,
- Marwan N. Sabbagh,
- Ryan R. Walsh,
- Miriam T. Weber,
- Melissa J. Armstrong,
- Jee A. Bang,
- Andrea C. Bozoki,
- Kimiko Domoto-Reilly,
- John E. Duda,
- John E. Duda,
- Jori E. Fleisher,
- Douglas R. Galasko,
- James E. Galvin,
- Jennifer G. Goldman,
- Samantha K. Holden,
- Lawrence S. Honig,
- Daniel E. Huddleston,
- James B. Leverenz,
- Irene Litvan,
- Carol A. Manning,
- Karen S. Marder,
- Alexander Y. Pantelyat,
- Victoria S. Pelak,
- Douglas W. Scharre,
- Sharon J. Sha,
- Holly A. Shill,
- Zoltan Mari,
- Joseph F. Quinn,
- Joseph F. Quinn,
- David J. Irwin,
- David J. Irwin,
- David J. Irwin,
- David J. Irwin
Affiliations
- Gregory D. Scott
- Department of Pathology, Oregon Health and Science University, Portland, OR, United States
- Gregory D. Scott
- Department of Pathology and Laboratory Services, VA Portland Medical Center, Portland, OR, United States
- Moriah R. Arnold
- Graduate Program in Biomedical Sciences, School of Medicine M.D./Ph.D. Program, Oregon Health and Science University, Portland, OR, United States
- Thomas G. Beach
- Civin Laboratory for Neuropathology and Brain and Body Donation Program, Banner Sun Health Research Institute, Sun City, AZ, United States
- Christopher H. Gibbons
- Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States
- Anumantha G. Kanthasamy
- Department of Physiology and Pharmacology, Center for Brain Sciences and Neurodegenerative Diseases, University of Georgia, Athens, GA, United States
- Russell M. Lebovitz
- Amprion Inc., San Francisco, CA, United States
- Afina W. Lemstra
- Department of Neurology, Amsterdam University Medical Center (UMC), Alzheimer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
- Leslie M. Shaw
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
- Charlotte E. Teunissen
- 0Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands
- Henrik Zetterberg
- 1Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
- Henrik Zetterberg
- 2Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- Henrik Zetterberg
- 3Department of Neurodegenerative Disease, University College London (UCL) Institute of Neurology, London, United Kingdom
- Henrik Zetterberg
- 4UK Dementia Research Institute at University College London, London, United Kingdom
- Henrik Zetterberg
- 5Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China
- Angela S. Taylor
- 6Lewy Body Dementia Association, Lilburn, GA, United States
- Todd C. Graham
- 6Lewy Body Dementia Association, Lilburn, GA, United States
- Bradley F. Boeve
- 7Department of Neurology and Center for Sleep Medicine, Mayo Clinic, Rochester, MN, United States
- Stephen N. Gomperts
- 8Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Neill R. Graff-Radford
- 9Department of Neurology, Mayo Clinic, Jacksonville, FL, United States
- Charbel Moussa
- 0Department of Neurology, Georgetown University Medical Center, Washington DC, CA, United States
- Kathleen L. Poston
- 1Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, United States
- Liana S. Rosenthal
- 2Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, United States
- Marwan N. Sabbagh
- 3Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, United States
- Ryan R. Walsh
- 4Barrow Neurological Institute and Muhammed Ali Parkinson Center, Phoenix, AZ, United States
- Miriam T. Weber
- 5Department of Neurology, University of Rochester, Rochester, NY, United States
- Melissa J. Armstrong
- 6Department of Neurology, University of Florida College of Medicine, Gainesville, FL, United States
- Jee A. Bang
- 7Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
- Andrea C. Bozoki
- 8Department of Neurology, University of North Carolina, Chapel Hill, NC, United States
- Kimiko Domoto-Reilly
- 9Department of Neurology, University of Washington, Seattle, WA, United States
- John E. Duda
- 0Parkinson's Disease Research, Education and Clinical Center, Michael J. Crescenz VA Medical Center, Philadelphia, PA, United States
- John E. Duda
- 1Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
- Jori E. Fleisher
- 2Department of Neurological Sciences, Rush Medical College, Chicago, IL, United States
- Douglas R. Galasko
- 3Department of Neurosciences, University of California, San Diego, San Diego, CA, United States
- James E. Galvin
- 4Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Miami, FL, United States
- Jennifer G. Goldman
- 5Shirley Ryan Abilitylab and Department of Physical Medicine and Rehabilitation and Neurology, Parkinson's Disease and Movement Disorders, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
- Samantha K. Holden
- 6Department of Neurology, University of Colorado School of Medicine, Aurora, CO, United States
- Lawrence S. Honig
- 7Columbia University Irving Medical Center, New York, NY, United States
- Daniel E. Huddleston
- 8Department of Neurology, Emory University School of Medicine, Atlanta, GA, United States
- James B. Leverenz
- 9Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, OH, United States
- Irene Litvan
- 3Department of Neurosciences, University of California, San Diego, San Diego, CA, United States
- Carol A. Manning
- 0Department of Neurology, University of Virginia, Charlottesville, VA, United States
- Karen S. Marder
- 7Columbia University Irving Medical Center, New York, NY, United States
- Alexander Y. Pantelyat
- 1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States
- Victoria S. Pelak
- 2Departments of Neurology and Ophthalmology, University of Colorado School of Medicine, Aurora, CO, United States
- Douglas W. Scharre
- 3Department of Neurology, Ohio State University Wexner Medical Center, Columbus, OH, United States
- Sharon J. Sha
- 1Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, United States
- Holly A. Shill
- 3Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, United States
- Zoltan Mari
- 4Lou Ruvo Center for Brain Health, Cleveland Clinic Lerner College of Medicine, Las Vegas, NV, United States
- Joseph F. Quinn
- 5Department of Neurology, Oregon Health and Science University, Portland, OR, United States
- Joseph F. Quinn
- 6Department of Neurology, VA Portland Medical Center, Portland, OR, United States
- David J. Irwin
- 7Department of Neurology, University of Pennsylvania Health System, Philadelphia, PA, United States
- David J. Irwin
- 8Digital Neuropathology Laboratory, Philadelphia, PA, United States
- David J. Irwin
- 9Lewy Body Disease Research Center of Excellence, Philadelphia, PA, United States
- David J. Irwin
- 0Frontotemporal Degeneration Center, Philadelphia, PA, United States
- DOI
- https://doi.org/10.3389/fneur.2021.805135
- Journal volume & issue
-
Vol. 12
Abstract
The Lewy Body Dementia Association (LBDA) held a virtual event, the LBDA Biofluid/Tissue Biomarker Symposium, on January 25, 2021, to present advances in biomarkers for Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLBs) and Parkinson's disease dementia (PDD). The meeting featured eight internationally known scientists from Europe and the United States and attracted over 200 scientists and physicians from academic centers, the National Institutes of Health, and the pharmaceutical industry. Methods for confirming and quantifying the presence of Lewy body and Alzheimer's pathology and novel biomarkers were discussed.
Keywords